Every recall we track for Teva Pharmaceuticals USA — 196 in all — plus the complaints and injury reports the public filed about them.
Teva Pharmaceuticals USA recalls 100-count doxylamine succinate/pyridoxine hydrochloride tablets due to failed dissolution specification. This may affect medication effectiveness. Check NDC 0591-2132-01 and lots 100025842, 100028023.
Teva Pharmaceuticals recalls 100-count Tretinoin Capsules (10mg) due to failed dissolution testing. This may affect medication effectiveness. Contact Teva for details.
Teva Pharmaceuticals USA recalls Mimvey (estradiol and norethindrone acetate tablets) due to mislabeling. Affected lots from 2022-2023 may be unsafe. Check your prescription label for NDC 0093-5455-28.
Teva Pharmaceuticals USA recalls Mimvey (estradiol and norethindrone acetate) 1 mg/0.5 mg tablets due to mislabeling. Affected lots expire 03/2022 to 01/2023. No remedy specified in recall notice.
Teva Pharmaceuticals USA recalls 4 mL Norepinephrine Bitartrate injections due to lack of sterility assurance. This could lead to infections if used improperly. Contact Teva for details.
Teva Pharmaceuticals USA recalls 10mL multiple-dose vials of Methylprednisolone Acetate Injectable Suspension due to lack of sterility assurance. This could lead to infections if used improperly.
Teva Pharmaceuticals USA recalls Penicillin V Potassium oral solution (125 mg/5mL) due to subpotent potency. This may result in less effective treatment for infections. Affected lots and expiration dates listed.
Teva Pharmaceuticals recalls Brinzolamide Ophthalmic Suspension 1% dropper bottles due to a cap notch that may break off and block the dropper, preventing product dispensing.
Teva Pharmaceuticals USA recalls Clon: 0.1 mg/day patches due to failed impurities/degradation specs. Rx only. Check NDC 0591-3508-04 and lot 1369117B.
Teva Pharmaceuticals USA recalls Cartia XT 12:00 mg capsules with incorrect expiration dates. Consumers should check labels for exp date 05/2023 and contact Teva for details.
Teva recalls AirDuo Digihaler 113/14 inhalers due to subpotent salmeterol levels. This may reduce medication effectiveness. Check your NDC 59310-520-08 for affected units.
Teva recalls AirDuo Digihaler 232/14 inhalers due to potential subpotent salmeterol levels. This may affect prescription inhalers sold in the US. Learn if your inhaler is affected and what to do.
Teva recalls AirDuo Digihaler 113/14 inhalers due to potential subpotent salmeterol levels. This may affect prescription asthma inhalers. Learn if you have the recalled product and what to do.
Teva recalls AirDuo Digihaler 232/14 inhalers due to potential subpotent salmeterol levels. This may affect medication effectiveness. Check your NDC 59310-530-08 for affected units.
Teva recalls AirDuo Digihaler 55/14 inhalers due to potential subpotent salmeterol levels. This may result in less effective treatment for asthma. Affected units have NDC 59310-111-06 and were manufactured in Ireland.
Teva Pharmaceuticals recalls Adenosine Injection vials due to potential lack of sterility. This could cause infections if used improperly. Affected lots expire April 2023.
Teva Pharmaceuticals USA recalls Vecuronium Bromide 10mg vials due to lack of sterility assurance. Affected lots expire through April 2023. Consumers should not use these products.
Teva recalls Metoclopramide Injection vials due to lack of assurance of sterility. Affected lots expire by 10/2021, 11/2021, 08/2023, or 09/2023. Stop using immediately if you have these vials.
Teva Pharmaceuticals recalls Alprostadil Injection USP 500 mg/mL vials due to lack of assurance of sterility. This could lead to infections if used improperly. Consumers should contact Teva for details.
Teva Pharmaceuticals recalls Amikacin Sulfate Injection vials due to lack of assurance of sterility. This could lead to infections if used improperly. Affected lots: 31329243B, exp. 05/2022.
Teva Pharmaceuticals USA recalls Adenosine Injection vials due to lack of assurance of sterility. This could lead to infections if used improperly. Affected units have specific NDC and lot numbers.
Teva recalls Leucovorin Calcium injection vials due to lack of sterility assurance. Affected lots expire through August 2023. Stop using if you have these vials.
Teva Pharmaceuticals USA recalls 7.5mg Cyclobenzaprine tablets with potential microbial contamination from a manufacturing batch defect. Affected products have specific NDC numbers and expiration dates. Consumers should contact the company for details.
Teva Pharmaceuticals USA recalls Haloperidol Decanoate Injection 100 mg/mL vials due to lack of sterility assurance. This could lead to infections if used improperly. Contact Teva for details.
Teva Pharmaceuticals recalls Octreotide Acetate Injection 50 mcg/mL vials due to lack of assurance of sterility. Affected lots expire June 2022. Consumers should contact Teva for details.
Teva Pharmaceuticals recalls Octreotide Acetate Injection 10:00 mcg/mL vials due to lack of assurance of sterility. This may cause infections. Affected lots: 31327466B, exp. 08/2021.
Teva Pharmaceuticals recalls specific lots of Methylprednisolone Acetate Injectable Suspension due to lack of sterility assurance. This injectable medication poses a risk of infection if used.
Teva Pharmaceuticals recalls Octreotide Acet: 1000 mcg/5mL vials due to lack of assurance of sterility. This could lead to infections if used improperly.
Teva Pharmaceuticals USA recalls 7.5mg cyclobenzaprine tablets due to microbial contamination in an excipient batch. Affected products have NDC 57237-266-01 or 1408824A, expiring 08/2023. No remedy specified in recall notice.
Teva Pharmaceuticals USA recalls 7.5mg cyclobenzaprine tablets due to potential microbial contamination in an excipient batch. Affected products have NDC 70199-014-01 or 1408822A, expiring 08/2023. No specific remedy is stated in the recall notice.
Teva Pharmaceuticals USA recalls Norepinephrine Bitartrate Injection vials due to lack of sterility assurance. This could cause infections if used improperly. Check your product details and contact Teva for instructions.
Teva Pharmaceuticals recalls specific lots of Methylprednisolone Acetate Injectable Suspension due to lack of sterility assurance. This medication may cause infection if used.
Teva recalls Leucovorin Calcium injection vials due to lack of sterility assurance. Affected lots expire through May 2023. Consumers should not use these vials.
Teva Pharmaceuticals USA recalls DAUNOrubicin Hydrochloride Injection 20 mg/4mL vials due to lack of sterility assurance. This could lead to infections if used improperly.
Teva Pharmaceuticals recalls Epoprostenol Sodium injection vials due to lack of sterility assurance. This drug, used for severe heart conditions, may cause infections if not properly sterile.
Teva Pharmaceuticals recalls Topotecan Injection vials with glass particles that could cause serious injury during infusion. Affected lots expire April 2022.
